Pages that link to "Q46774737"
Jump to navigation
Jump to search
The following pages link to Serum visfatin and its relation to insulin resistance and inflammation in type 2 diabetic patients with and without macroangiopathy (Q46774737):
Displaying 8 items.
- Nicotinamide Phosphoribosyltransferase in Human Diseases (Q35581515) (← links)
- Circulating visfatin level and visfatin/insulin ratio in obese women with metabolic syndrome (Q35990401) (← links)
- Extracellular nicotinamide phosphoribosyltransferase (NAMPT/visfatin) inhibits insulin-like growth factor-1 signaling and proteoglycan synthesis in human articular chondrocytes (Q36084973) (← links)
- Relationship between adipocytokines and cardiovascular risk factors in patients with type 2 diabetes mellitus. (Q36285571) (← links)
- Effects of bariatric surgery on adipokine-induced inflammation and insulin resistance (Q36915215) (← links)
- Nampt: linking NAD biology, metabolism and cancer (Q37334248) (← links)
- Associations between tissue visfatin/nicotinamide, phosphoribosyltransferase (Nampt), retinol binding protein-4, and vaspin concentrations and insulin resistance in morbidly obese subjects. (Q37400624) (← links)
- Visfatin in overweight/obesity, type 2 diabetes mellitus, insulin resistance, metabolic syndrome and cardiovascular diseases: a meta‐analysis and systemic review (Q37864255) (← links)